Who owns MOONLAKE IMMUNOTHERAPEUTICS?
- CUSIP Number: 61559x904
Tip: Access positions for across all investors
Analyze quarterly positions in Moonlake Immunotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Moonlake Immunotherapeutics stock
Who bought or sold MOONLAKE IMMUNOTHERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Simplex Trading | 114k | $1.5M | -44% | Dec 2025 |
|
| IMC-Chicago | 68k | $890k | 24% | Dec 2025 |
|
| Group One Trading | 60k | $786k | -64% | Dec 2025 |
|
| Persistent Asset Partners | 126.00 | $30k | 107% | Dec 2025 |
|
Who sold out of Moonlake Immunotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Silverarc Capital Management | Sep 2025 | 65k | $466k |